Yazbeck & Co., formerly Yazbeck Investments, is a private investment firm founded in 2008 with a focus on growth-oriented companies. Its main investment areas include pharmaceuticals and healthcare, agriculture, advanced technologies and sustainable solutions. The company has invested more than 100 million US dollars in startups and has been involved in over 20 investments and exits. One of its active investments is Tillat Pharmaceuticals, which develops and commercializes halal-compliant medicines.